ALLMedicine™ Allergy Immunotherapy Center

Sep 21st, 2022 - Bakground: Intralymphatic immunotherapy has been proposed as a new, more effective, modality for allergy immunotherapy. With ultrasound- guided injections into the lymph node the allergen is injected directly to the secondary lymphoid organ to sti...

Aug 19th, 2022 - The current review describes the incidence and risk for anaphylaxis due to allergy injections. The incidence of fatal anaphylaxis occurs with approximately one in 7.2 million injection visits. Severe anaphylaxis may occur once in every 160 000 vis...

Jul 27th, 2022 - Allergic rhinitis (AR) is an inflammatory disorder, characterised by pruritus, sneezing, rhinorrhoea, and nasal congestion. It is one of the most common disorders worldwide, with an estimated global prevalence of 10-30%. AR is a chronic and progre...

Mar 23rd, 2022 - This pilot study is an observational study with subsequent use of coded biological material. The blood sera are collected and prepared at the Allergy Units at the University Hospital Zurich (USZ) or Centre for Rhinology and Allergology Wiesbaden (...

Jan 6th, 2022 - Pollen from grasses and trees can trigger allergic rhinitis (AR), where the symptoms and associated consequences can negatively affect quality of life (QoL). The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) is frequently used in clinic...

Sep 21st, 2022 - Bakground: Intralymphatic immunotherapy has been proposed as a new, more effective, modality for allergy immunotherapy. With ultrasound- guided injections into the lymph node the allergen is injected directly to the secondary lymphoid organ to sti...

Jul 27th, 2022 - Allergic rhinitis (AR) is an inflammatory disorder, characterised by pruritus, sneezing, rhinorrhoea, and nasal congestion. It is one of the most common disorders worldwide, with an estimated global prevalence of 10-30%. AR is a chronic and progre...

Mar 23rd, 2022 - This pilot study is an observational study with subsequent use of coded biological material. The blood sera are collected and prepared at the Allergy Units at the University Hospital Zurich (USZ) or Centre for Rhinology and Allergology Wiesbaden (...

Oct 14th, 2020 - Allergic diseases represent a major health issue worldwide and epidemiological studies in Melbourne, Australia, have reported a high prevalence of rhinitis (hayfever) and atopy (genetic tendency to make allergy antibody) in Asian and Caucasian sub...

May 28th, 2019 - In this clinical study we aim to determine the effect of allergy immunotherapy in decreasing asthma and allergy related disease in children who had multiple episodes of wheezing and who are at high risk for developing persisting asthma. These risk...

Sep 26th, 2022 - Two new studies highlight the challenges for patients in sticking with allergy shots or sublingual immunotherapy. Both studies add to arguments in favor of having frank discussions before selecting these options and of making it easier to complete...

Mar 9th, 2022 - Oral immunotherapy (OIT) is a promising long-term food allergy regimen, but it can be so stressful that patients often quit. Providing young patients and their families with psychological support can increase the odds that they'll complete the ful...

Nov 30th, 2021 - A resolution is needed in the ongoing controversy between US and European allergists over the best approach to subcutaneous allergy immunotherapy (SCIT), "since it is likely that one or the other group of patients is receiving sub-optimal treatmen...

Jul 7th, 2021 - This is part 1 of a three-part series. Part 2 is here. Part 3 is here. For the 32 million people in the United States with food allergies, those who seek relief beyond constant vigilance and EpiPens face a confusing treatment landscape. In January...

Jan 3rd, 2021 - In January, MedPage Today covered the FDA's approval of an oral peanut allergy immunotherapy, which was seen as heralding a new era in food allergy treatment. In this follow-up feature, we review some of the developments occurring since. The timin...